Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rosen who wrote (2596)	3/2/1998 1:20:00 PM
From: Bruce Olsten	Read Replies (1) \| Respond to of 7041

To all: For what it is worth, here is a link to alt.support.impotence from a person who is in a Vasomax clinical trial. x1.dejanews.com I am neither short nor long Zonagen and have no ax to grind, so don't shoot the messenger!

To: Bruce Rosen who wrote (2596)	3/2/1998 4:37:00 PM
From: Bill Wexler	Respond to of 7041

Zonagen does not have an ED medication. Zonagen has presented no evidence to date that oral phentolamine is effective in the treatment of ED. Zonagen understands that its stock price is dependent on investors believing the (false) story that Zonagen has a snowball's chance in hell of selling an ED drug. Unfortunately, this will never be the case. Zonagen continues to fraudulently promote its stock. However, the details of Zonagen's fraud are now widely known and I believe that the stock is still grossly overvalued. Zonagen will soon trade in the low single digits.